Sarcopenia vs body mass index (BMI) as a prognostic biomarker in patients with metastatic clear cell renal cell carcinoma (mCCRCC) in the era of first line immune checkpoint inhibitors (ICIs)

被引：0
|
作者：
La Course, Bryce Douglas
Orcutt, Delaney
Gross, Evan
Fintelmann, Florian J.
Master, Viraj A.
Hall, Evan Thomas
Wrobel, Maria Marta
Psutka, Sarah P.
机构：
[1] Univ Washington, Sch Med, Seattle, WA USA
[2] Vanderbilt Univ, Nashville, TN USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Div Thorac Imaging & Intervent, Boston, MA USA
[4] Emory Univ, Atlanta, GA USA
[5] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA USA
[6] Ludwig Maximilians Univ Munchen, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16515
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Association of serum iron and response to immune checkpoint inhibitors (ICIs) in metastatic clear cell renal cell carcinoma (mccRCC)
    Rathi, Nityam
    Stenehjem, David D.
    Agarwal, Neeraj
    Hahn, Andrew W.
    Sirohi, Deepika
    Sharma, Prayushi
    Koh, Mei Yee
    Maughan, Benjamin Louis
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [2] A novel nomogram and prognostic factor for metastatic renal cell carcinoma survival in the era of immune checkpoint inhibitors (ICIs)
    Alradhi, Mohammed
    Zhang, Zewen
    Safi, Mohammed
    Al-danakh, Abdullah
    Aldhbi, Mokhtar
    Baldi, Salim
    Kui, Li
    Alradhi, Abdulaziz
    Bin Hamri, Saeed
    lo, Ka Lun
    Zhao, Yi
    Jin, Yang
    FRONTIERS IN PHARMACOLOGY, 2023, 13
  • [3] Prognostic factors for patients with advanced renal cell carcinoma (aRCC) in the era of first-line (1L) treatment with immune checkpoint inhibitors (ICIs).
    Mantia, Charlene
    Jegede, Opeyemi
    Regan, Meredith M.
    Atkins, Michael B.
    McDermott, David F.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)
    Simonaggio, Audrey
    Epaillard, Nicolas
    Pobel, Cedric
    Moreira, Marco
    Oudard, Stephane
    Vano, Yann-Alexandre
    CANCERS, 2021, 13 (02) : 1 - 22
  • [5] Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials
    Zhuang, Tony Zibo
    Case, Katherine
    Olsen, Timothy Anders
    Brown, Jacqueline T.
    Carthon, Bradley C.
    Kucuk, Omer
    Goldman, Jamie
    Harris, Wayne
    Bilen, Mehmet Asim
    Nazha, Bassel
    CANCERS, 2022, 14 (12)
  • [6] Biomarkers in metastatic renal cell carcinoma in the era of immune checkpoint inhibitors
    Tripathi, Abhishek
    Lin, Edwin
    Agarwal, Neeraj
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [7] Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Lee, Ji Hyun
    Hwang, Soohyun
    Jee, ByulA
    Kim, Jae-Hun
    Lee, Jihwan
    Chung, Jae Hoon
    Song, Wan
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Park, Se Hoon
    Kwon, Ghee Young
    Kang, Minyong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [8] Effect of body mass index (BMI) on efficacy of immune checkpoint inhibitors (ICIs) in patients with metastatic urothelial carcinoma (mUC) in a real-world setting
    Lynn, David
    Hobeika, Charbel
    Patgunarajah, Ubenthira
    Dawsey, Scott
    Pramod, Nikhil
    Wei, Wei
    Nair, Monica
    Maroli, Kimberly
    Martin, Allison
    Ornstein, Moshe Chaim
    Wee, Christopher Eing
    Gilligan, Timothy D.
    Nizam, Amanda
    Bonham, Amanda
    Mian, Omar Y.
    Pavicic, Paul G.
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 571 - 571
  • [9] Prognostic significance of body mass index in patients with metastatic renal cell carcinoma receiving first-line therapies
    Sato, Keigo
    Takemura, Kosuke
    Oki, Ryosuke
    Urasaki, Tetsuya
    Yoneoka, Yusuke
    Fujiwara, Ryo
    Yasuda, Yosuke
    Oguchi, Tomohiko
    Numao, Noboru
    Yamamoto, Shinya
    Yonese, Junji
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (04) : 269e1 - 269e6
  • [10] Absolute eosinophil count as predictive biomarker of irAEs in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICIs).
    Giorgione, Roberta
    Pillozzi, Serena
    Mela, Marinella Micol
    Giommoni, Elisa
    Paderi, Agnese
    Doni, Laura
    Pellegrini, Elisa
    Di Costanzo, Alessandro
    Antonuzzo, Lorenzo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
12345